U.S. Physical Therapy's fundamental outlook is characterized by erratic revenue swings and severe margin compression, with gross margins collapsing to 14.5% in Q1 2026 from a historical 17-25% range, suggesting significant cost structure vulnerability. The com...
Price trend, volume and key moving averages
Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 5, 2026 | $0.75-7.9% vs $0.81 | $214M+1.3% vs $211M |
Q2 2026 May 6, 2026 | $0.46-16.4% vs $0.55 | $198M-1.3% vs $201M |
Q1 2026 Feb 25, 2026 | $0.67+0.0% vs $0.67 | $203M+1.4% vs $200M |
Q4 2025 Nov 5, 2025 | $0.66-1.5% vs $0.67 | $164M-18.0% vs $200M |
Freestone Grove Partners LP acquired a new stake in shares of U.S. Physical Therapy, Inc. (NYSE: USPH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 9,969 shares of the company's stock, valued at approximately $685,000. Freestone Grove Partners LP owned 0.07%
BlackRock Inc. bought a new stake in U.S. Physical Therapy, Inc. (NYSE: USPH) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 2,264,202 shares of the company's stock, valued at approximately $155,505,000. BlackRock Inc. owned about 14.88% of U.S. Physical Therapy at
U.S. Physical Therapy (NYSE: USPH) is pursuing growth through clinic openings, acquisitions and a newer hospital-alliance strategy that Chief Executive Officer Chris Reading said could expand patient volumes and improve reimbursement. Speaking at an investor event, Reading said the company operates in 45 states with just under 800 locations focused primarily on orthopedic and musculoskeletal care,
U.S. Physical Therapy NYSE: USPH is pursuing growth through clinic openings, acquisitions and a newer hospital-alliance strategy that Chief Executive Officer Chris Reading said could expand patient volumes and improve reimbursement.
Benchmark USPH against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for U.S. Physical Therapy, Inc. (USPH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $83.17 | $1.27B | 58.57 | 16.33% | 1.93% | 1.97% | 2.17% | |
| $3.50 | $79.83M | -3.68 | -39.65% | 21.44% | 2.9% | — | |
| $13.25 | $428.06M | -4.52 | -21.56% | -9.84% | -27.1% | — | |
| $222.86 | $3.48B | 29.06 | 16.94% | 9% | 12.88% | — | |
| $176.32 | $10.28B | 30.19 | 18.72% | 6.9% | 16.51% | — | |
| $29.37 | $2.73B | -2.42 | 5.04% | -33.44% | -46.01% | — |
U.S. Physical Therapy, Inc. (USPH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
U.S. Physical Therapy, Inc. (USPH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 6, 2026·SEC
Jul 6, 2026·SEC
May 19, 2026·SEC
Get notified when USPH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
U.S. Physical Therapy, Inc. (USPH) stock FAQ — growth, dividends, profitability & financials explained
U.S. Physical Therapy, Inc. (USPH) reported $704.3M in revenue for fiscal year 2025. This represents a 2087% increase from $32.2M in 1996.
U.S. Physical Therapy, Inc. (USPH) grew revenue by 16.3% over the past year. This is strong growth.
Yes, U.S. Physical Therapy, Inc. (USPH) is profitable, generating $2.3M in net income for fiscal year 2025 (1.9% net margin).
Yes, U.S. Physical Therapy, Inc. (USPH) pays a dividend with a yield of 2.17%. This makes it attractive for income-focused investors.
U.S. Physical Therapy, Inc. (USPH) has a return on equity (ROE) of 2.0%. This is below average, suggesting room for improvement.
U.S. Physical Therapy, Inc. (USPH) generated $62.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
